Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2017
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:European_Medicines_Agency |
| gptkbp:ATCCode |
L01XC03
|
| gptkbp:biosimilar |
gptkb:Herceptin
|
| gptkbp:brand |
gptkb:trastuzumab
|
| gptkbp:form |
solution for infusion
|
| gptkbp:genericName |
gptkb:trastuzumab
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ontruzant
|
| gptkbp:indication |
gptkb:cancer
gastric cancer |
| gptkbp:manufacturer |
gptkb:Samsung_Bioepis
|
| gptkbp:marketedIn |
gptkb:European_Union
gptkb:United_States |
| gptkbp:mechanismOfAction |
HER2 receptor antagonist
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:type |
gptkb:monoclonal_antibody
|
| gptkbp:bfsParent |
gptkb:trastuzumab
gptkb:Samsung_Bioepis |
| gptkbp:bfsLayer |
7
|